FINEORGNSEFine Organic Industries LimitedMediumNeutral
Announced Fri, 9 May · 19:03 IST

Fine Organic Industries Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin PressureInvestor Communications View source PDF

FINEORG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fine Organic Industries filed its Investor Presentation for May 2025 with the exchanges, sharing detailed business and financial highlights. For FY25, standalone revenue grew 13% YoY to Rs 2,205 crore, but EBITDA was flat at Rs 481 crore with margin contracting to 21.7% from 24.7% due to higher raw material and freight costs. PAT grew 6% to Rs 390 crore. Q4FY25 was weaker with EBITDA margin falling to 18.8% (from 25.4% YoY) and PAT down 15% YoY to Rs 89 crore. The company remains net cash positive with a debt-free balance sheet, ROCE of 19.4% and RoNW of 17.6%. All plants are running at full capacity except the newer Patalganga plant which is ramping up. The company announced plans to set up wholly owned subsidiaries in the USA and UAE. Export revenue contributed 57% of FY25 revenues.

Likely market impact

Despite strong revenue growth, the sharp drop in Q4 margins signals near-term pressure on profitability from elevated input costs, which may weigh on the stock in the short term. However, a debt-free balance sheet, high return ratios, capacity expansion plans and international subsidiary plans support the long-term growth story.